Skip to main content
Top

International Journal of Clinical Oncology

Issue 3/2006

Content (15 Articles)

INTRODUCTION TO REVIEW ARTICLES

Current topics and the clinical effects of target-based antineoplastic agents

Yoshihiko Maehara, Akinori Egashira, Yoshihiro Kakeji

REVIEW ARTICLE

Methodological aspects of current problems in target-based anticancer drug development

Takeharu Yamanaka, Tatsuro Okamoto, Yukito Ichinose, Shinya Oda, Yoshihiko Maehara

REVIEW ARTICLE

Biological and clinical implications of EGFR mutations in lung cancer

Tetsuya Mitsudomi, Takayuki Kosaka, Yasushi Yatabe

REVIEW ARTICLE

Trastuzumab and breast cancer: developments and current status

Eriko Tokunaga, Eiji Oki, Kojiro Nishida, Tadashi Koga, Akinori Egashira, Masaru Morita, Yoshihiro Kakeji, Yoshihiko Maehara

REVIEW ARTICLE

Molecular targeting therapy for renal cell carcinoma

Masatoshi Eto, Seiji Naito

ORIGINAL ARTICLE

Management of sentinel lymph nodes in malignant skin tumors using dynamic lymphoscintigraphy and the single-photon-emission computed tomography/computed tomography combined system

Tsuyoshi Ishihara, Atsushi Kaguchi, Shigeto Matsushita, Shinya Shiraishi, Seiji Tomiguchi, Yasuyuki Yamashita, Toshiro Kageshita, Tomomichi Ono

ORIGINAL ARTICLE

Historical control study of paclitaxel–carboplatin (TJ) versus conventional platinum-based chemotherapy (CAP) for epithelial ovarian cancer

Reiko Numazaki, Etsuko Miyagi, Ryo Onose, Tsuneo Nakazawa, Ken Sugiura, Kunio Asukai, Hiroki Nakayama, Atsushi Miyamatsu, Naoyuki Okamoto, Fumiki Hirahara

ORIGINAL ARTICLE

Malignant change secondary to fibrous dysplasia

Manabu Hoshi, Seiichi Matsumoto, Jun Manabe, Taisuke Tanizawa, Toshio Shigemitsu, Naohiro Izawa, Takeuchi Kengo, Noriyoshi Kawaguchi

ORIGINAL ARTICLE

Primary chemotherapy-associated effect of second-line chemotherapy on survival of patients with advanced ovarian cancer

Seiji Isonishi, Masanori Hirama, Motoaki Saitou, Makoto Yasuda, Tadao Tanaka

CASE REPORT

Carcinomatous meningitis from non-small-cell lung cancer responding to gefitinib

Mitsuaki Sakai, Shigemi Ishikawa, Hiromichi Ito, Yuichiro Ozawa, Tatsuo Yamamoto, Masataka Onizuka, Yuzuru Sakakibara

CASE REPORT

Cholangiocellular carcinoma that produced both granulocyte-colony-stimulating factor and parathyroid hormone-related protein

Tetsuro Sohda, Hiroshi Shiga, Hidetoshi Nakane, Hiroshi Watanabe, Morishige Takeshita, Shotaro Sakisaka

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine